Laurus Labs Limited (LAURUSLABS NSE) stock market data APIs
INR988.9818
2.9(0.3%)
as of November 20, 2025
Try our APIs with
free plan!
Laurus Labs Limited Financial Data Overview
Price chart is built with
Anychart
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Prev. Close
988.9818
Open
991.8818
High
992.3414
Low
962.1153
52 wk Range
500.0541-1033.5
Market Cap
532 956 M
P/E Ratio
78.0934
Shares Outstanding
540 M
Revenue
63 584 M
EPS
3.61
Dividends (Yield)
0.0016
Beta
0.404
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Laurus Labs Limited (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Laurus Labs Limited data using free add-ons & libraries
Get Laurus Labs Limited Fundamental Data
Laurus Labs Limited Fundamental data includes:
- Net Revenue: 63 584 M
- EBITDA: 14 700 M
- Earnings Per Share: 12
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-23
- EPS/Forecast: 2.57
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Laurus Labs Limited News
New
How Recent Developments Are Shaping the Laurus Labs Investment Story
Laurus Labs has seen a modest increase in its fair value estimate, now rising from ₹694.85 to ₹724.14 amid an uptick in revenue growth projections. This upward revision reflects renewed optimism a...
Gilead Scores A 'Solid Win' For Its Biggest Moneymaker; Shares Jump
Gilead stock popped Monday after the biotech giant said it signed deals with three generic drugmakers to delay their Biktarvy copycats. Continue Reading View Comments
Gilead stock rises after settling Biktarvy patent disputes
Investing.com -- Gilead Sciences Inc. (NASDAQ:GILD) stock rose 4.5% Monday after the company announced it had settled patent disputes with multiple generic drugmakers over its HIV treatment Biktarvy. ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
